102.645 articles found

Life Expectancy for Parkinson Patients at Hoehn and Yahr Stage 5.

Li W, Saffari E, Ng HL, Tay KY, Au WL, Tan LCS.

Mov Disord Clin Pract · 2026-09-27

DOI: 10.1002/mdc3.70830PMID: 42802596

Distinct EEG functional network alterations in Parkinson's disease and multiple system atrophy.

Chen D, Tang H, Pan Y, Zhang Z, Wang W, Leng F, Yan H, Sang H, Li K, Li F, Sun Y, Chen J, Sun W, Zhang J, Wang Z, Wei L.

Neuroimage Clin · 2026-09-27

DOI: 10.1016/j.nicl.2026.104072PMID: 42810100

Short-term efficacy and safety of tavapadon for Parkinson's disease: An exploratory systematic review and meta-analysis of randomized clinical trials.

Campos TS, Pereira PS, Pires Marques ME, de Sousa Fernandes LR, Grassi Simões PR, Ribeiro TC, de Oliveira MPR, Andrade Nascimento Almeida M, Gonçalves OR, Nery GG, Andrade PGG.

Parkinsonism Relat Disord · 2026-09-27

DOI: 10.1016/j.parkreldis.2026.108995PMID: 42822261

In Vitro Screening of <i>Sargassum</i> spp. Ethanolic Extracts for Antioxidant Activity and Inhibition of Disease-Associated Enzymatic Targets Related to Diabetes, Alzheimer's Disease, and Parkinson's Disease.

Ali MY, Park SE, Jung HA, Choi JS.

Int J Mol Sci · 2026-09-27

DOI: 10.3390/ijms27198643PMID: 42883891

Machine Learning for Parkinson's Disease Biomarkers: A Systematic Review of Diagnostic Performance, Risk of Bias, and Clinical Translation Readiness.

Pinto Neto O, Pinho TOR.

Brain sciences · 2026-09-26

DOI: 10.3390/brainsci16101027PMID: 42939280

Machine Learning for Parkinson’s Disease Biomarkers: A Systematic Review of Diagnostic Performance, Risk of Bias, and Clinical Translation Readiness

Pinto Neto O, Pinho T.

Brain sciences · 2026-09-26

Beyond bacteria: a multi-omics view of the gut–brain axis in Parkinson’s disease

Han H, Luo O, Li K, Rahaman S, Ok E, Zhang L, Liang M, Lin H.

Frontiers in cellular and infection microbiology · 2026-09-26

Image-guided programming improves motor control in chronic subthalamic nucleus deep brain stimulation in Parkinson's disease: A prospective study.

Lee JS, Ha J, Kim S, Cho JW, Lee JI, Youn J.

J Parkinsons Dis · 2026-09-26

DOI: 10.1177/1877718x261492273PMID: 42798288

A review of FDG-PET biomarker analysis methods in Parkinson's disease.

Reimers E, Bevington C, Stoessl AJ, Sossi V.

J Parkinsons Dis · 2026-09-26

DOI: 10.1177/1877718x261492275PMID: 42798283

Tremor relief after gamma knife thalamotomy for Parkinson's disease.

Reyes JS, Bouras A, Hadjipanayis CG, Lunsford LD, Niranjan A.

Neurosurg Rev · 2026-09-26

DOI: 10.1007/s10143-026-04518-0PMID: 42799781

Insights into X-linked Dystonia-Parkinsonism and Spinocerebellar Ataxia type 36 Through the Lens of Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.

Patel M, Das S, Kumari AP, Kumar A.

Mol Neurobiol · 2026-09-26

DOI: 10.1007/s12035-026-06209-9PMID: 42799858

Symptomatic Rescue or Disease Modification? A Critical Review of Levodopa and Phytochemical Interventions in Caenorhabditis elegans Models of Parkinson's Disease.

Aktaş E, Berk Ş.

Mol Neurobiol · 2026-09-26

DOI: 10.1007/s12035-026-06241-9PMID: 42799932